home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

How A Genetic Mutation Influences Schizophrenia

 
  November, 2 2005 9:46
your information resource in human molecular genetics
 
     
A major risk factor for schizophrenia is a genetic mutation called 22q11.2 microdeletion, which occurs in 1 of 4000 people. One third of people with this mutation develop schizophrenia or another psychotic disorder. Two groups shed light on the linkage between the mutated genes and the cognitive and physiological changes that may be involved in schizophrenia, in the November issue of Nature Neuroscience.

In one study, Doron Gothelf and colleagues administered psychological tests to children with and without 22q11.2 syndrome and examined them again several years later, in late adolescence or early adulthood. They found a strong effect of a particular mutation in the gene COMT, which produces a protein that breaks down the neurotransmitter dopamine. Subjects with this mutation had an abnormal decrease in the size of the prefrontal cortex (a brain region involved in reasoning and control), as well as lower IQs and more frequent psychotic symptoms than subjects without the mutation.

In the other study, Maria Karayiorgou and colleagues examined a mouse model of schizophrenia that contains a mutation in the gene for the enzyme proline dehydrogenase (PRODH), which breaks down the proposed neuromodulator proline. They report that this deficiency in PRODH alters the expression of the COMT gene. Interaction between these two genes modulated several schizophrenia-related phenotypes in these mice, such that COMT inhibition exaggerated or induced behavioral deficits in the PRODH-deficient mice. This synergistic interaction between these genes could explain the high disease risk associated with deletions in the 22q11.2 locus.

Author contact:

Doron Gothelf (Stanford University, CA, USA)
E-mail: gothelf@stanford.edu

Author contact:

Maria Karayiorgou (The Rockefeller University, New York, NY, USA)
E-mail: karayim@rockefeller.edu

Abstracts available online: Paper 1; Paper 2

(C) Nature Neuroscience.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.